Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course

Original price was: $149.00.Current price is: $44.00.

Digital Download: You will receive a download link via your order email
Save up to 85% compared to Salepage prices. In addition, earn additional points. Save more on your next order.

Please contact email: [email protected] if you have any questions about this course.

Category: Health and Medical Tags: Jason Cota & William “Barry” Inman, Jason Cota & William “Barry” Inman - Advanced Infectious Disease Pharmacology Course, Tags: Advanced Infectious Disease Pharmacology Course

Description

You are currently accessing the institutional-grade blueprint for Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.

Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course

Name: Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course
Availability: InStock

In the new world where COVID-19 is taking center stage, having solid infectious disease pharmacology knowledge is essential for your patient care.

If you don’t know the core principles, how can you identify when something is new, different or strange? And missing a key finding in a patient can be the difference between a treated infection and sepsis.

Let two infectious disease experts sharpen your skills…

This carefully curated online course covers proper prescribing, patient education, and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases.

Jason and Barry not only teach the foundations of infectious disease pharmacology, but ground them in real-life experiences…

“Jason had a great mix of technical biochemical info and meds with the practical day-to-day use of this info.” — Karen M, NP

“Loved [Barry’s] incorporation of personal and work experience!” — Joy L, RN

PLUS, get special bonus content on COVID-19 vaccines and treatments!

This self-paced video training will give you the skills to:

Confidently select the best empiric therapy before culture data is available
Narrow antibiotic coverage at the right time like a seasoned pro
Expertly reduce bacterial resistance — your colleagues will think you wrote the IDSA guidelines!
Interpret culture and sensitivity results to select the most narrow and targeted antibiotic therapy
Earn up to 16.25 CE hours – INCLUDING up to 7.3 pharmacology CE hours
… And so much more!

Here’s what you’ll cover in this state-of-the-art online training course:

Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians

— with Jason Cota, PharmD, MS

Antimicrobials

Drug classes
Pharmacokinetic Properties
Concentration-dependent killing
Time-dependent killing
Post-antibiotic effect
Common interactions with other drugs

Antibacterial Allergies — Sulfa and Penicillin

Define true allergy
Sulfonamide antibiotics vs non-antibiotics
Penicillin — Cephalosporin cross-sensitivity

Bacteria

Differentiation
Normal flora
Common pathogens

Antibacterial Resistance — Contributing Factors

Trends
Mechanisms of resistance
Contributing factors

Methicillin-Resistant Staphylococcus Aureus —
Community versus Hospital Acquired

Differentiating between CA- and HA-MRSA
Current clinical practice guidelines
Pharmacologic management

Enterobacteriaceae Resistance

Extended Spectrum Beta-Lactamase (ESBL)
What are ESBLs
Pharmacologic management
Carbapenem-Resistant Enterobacteriaceae (CRE)
What are CREs
Pharmacologic management

Urinary Tract Infections

Bacterial Etiology, Signs and Symptoms and Diagnosis
Cystitis and pyelonephritis
Complicated and uncomplicated
UTIs in pregnancy
Treatment (IDSA Guideline Treatment Algorithm)
Acute
Recurrent and relapse

Clostridium Difficile Infection

Risk factors
Pharmacology management
Fecal Transplantation
Probiotics literature review

Community-Acquired Pneumonia

Bacterial etiology
Diagnosis
Typical vs. atypical
Treatment (IDSA/ATS Guidelines) and monitoring
Outpatient vs. inpatient
Empiric treatment

Healthcare-Associated Pneumonia

Bacterial etiology
Treatment (IDSA/ATS Guidelines)

Upper Respiratory Tract Infections

Sinusitis and pharyngitis
Etiology (Viral vs. Bacterial)
Treatment

Skin and Soft Tissue Infections

Cellulitis
Bacterial etiology
Strep. vs. Staph. vs. MRSA
Signs & symptoms
Treatment (IDSA Guidelines)

Influenza

Clinical features
Diagnosis
Pharmacology management

Immunizations (Adult)

Types of Vaccines
General recommendations
Contraindications & precautions

Infection Control Challenges: Real Risks for Patients and Staff

— with William “Barry” Inman, BA-BS, CIC

A Summary of Current Recommendations From the CDC, SHEA, IDSA, APIC and the Joint Commission

Health-Care Associated Infections: Strategies to Control-Reduce-Eliminate

Catheter-Associated Urinary Tract Infections
Surgical Site Infections
Ventilator-Associated Pneumonias
Non-ventilator Associated Infections (overlooked HAI)
Central-Line Associated Bloodstream Infections

The Latest Multi-Drug Resistant Microorganism Guidelines

Carbapenem-resistant enterobacteriaceae
Clostridium difficile
Methicillin-resistant staphylococcus aureus
Vancomycin resistant enterococcus
Acinetobacter baumannii

Influenza

Avian vs. swine vs. seasonal influenza
H1N1 pandemic results
When to treat? When not to treat?
Treatment with anti-virals and antibiotics
New vaccines for flu

Vaccination Recommendations for Healthcare Personnel

Zoster/shingles
Pneumoccocal
MMR, Tdap, etc.

Emerging Infectious Diseases (Zoonotic)

Ebola: What we learned
Mosquito-borne (“Zika”, Dengue, Chickungunya, West Nile)
Tick-borne (Lyme and Babesia)
Cryptosporidiosis

Bloodborne Pathogens

Hepatitis B
- Vaccination protocol for healthcare personnel
- Staff follow-up after significant exposures
- Treatments for persons chronically infected
- Outbreaks in healthcare
Hepatitis C
- Treatment “cures” in 12-24 weeks
- Outbreaks in healthcare-dialysis settings
HIV/AIDS
- New one pill daily treatment
- Healthcare exposure and appropriate prophylaxis

Tuberculosis

Today’s best approaches to treatment
Skin testing vs. blood test for exposure
Follow-up guidelines for healthcare workers conversion testing

Meet the Course Experts:

Jason Cota, PharmD, MS, is an associate professor and the vice chair of the Pharmacy Practice Department at the University of the Incarnate Word Feik School of Pharmacy. He also has over 10 years of experience practicing as an infectious diseases clinical pharmacist at the San Antonio Military Medical Center, where he is a credentialed provider with prescriptive authority.

Click here for information about Jason Cota

William “Barry” Inman, BA-BS, CIC, has 31 years of experience as an epidemiologist. He works for the Brevard County Health Department in Merritt Island, Florida and is a faculty member for Brevard Community College and the University of Central Florida teaching classes on infection control.

Sale Page: https://catalog.pesi.com/sales/hc_c_001348_pharminfectiousdiseases_organic-141055
Archive: https://archive.ph/wip/ezBKD

Delivery Method

– After your purchase, you’ll see a View your orders link which goes to the Downloads page. Here, you can download all the files associated with your order.

– Downloads are available once your payment is confirmed, we’ll also send you a download notification email separate from any transaction notification emails you receive from Forimc.me.

– Since it is a digital copy, our suggestion is to download and save it to your hard drive. In case the link is broken for any reason, please contact us and we will resend the new download link.

– If you cannot find the download link, please don’t worry about that. We will update and notify you as soon as possible at 8:00 AM – 8:00 PM (UTC+8).

Thank You For Shopping With Us!

Reviews

There are no reviews yet.

Be the first to review “Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course” Cancel reply

Your rating *

Your review *

Name *

Email *

Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results. Asset Classification:

Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course

Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course

Delivery Method

Reviews

Be the first to review “Jason Cota & William “Barry” Inman – Advanced Infectious Disease Pharmacology Course” Cancel reply

Related products

Register

Login